Your browser doesn't support javascript.
loading
Development of a predictive score of axillary lymph node dissection based on targeted axillary dissection in patients with breast cancer diagnosis, affected lymph nodes, and neoadjuvant treatment.
Flores-Funes, Diego; Aguilar-Jiménez, José; Martínez-Gálvez, María; Ibáñez-Ibáñez, María José; Carrasco-González, Luis; Gil-Izquierdo, José Ignacio; Chaves-Benito, María Asunción; Ayala-De La Peña, Francisco; Nieto-Olivares, Andrés; Aguayo-Albasini, José Luis.
Afiliación
  • Flores-Funes D; General Surgery Department, Morales Meseguer University Hospital, Murcia, Spain. Electronic address: diego.ff90@gmail.com.
  • Aguilar-Jiménez J; General Surgery Department, Morales Meseguer University Hospital, Murcia, Spain.
  • Martínez-Gálvez M; Radiology Department, Morales Meseguer University Hospital, Murcia, Spain.
  • Ibáñez-Ibáñez MJ; Nuclear Medicine, Morales Meseguer University Hospital, Murcia, Spain.
  • Carrasco-González L; General Surgery Department, Morales Meseguer University Hospital, Murcia, Spain.
  • Gil-Izquierdo JI; Radiology Department, Morales Meseguer University Hospital, Murcia, Spain.
  • Chaves-Benito MA; Pathology Department, Morales Meseguer University Hospital, Murcia, Spain.
  • Ayala-De La Peña F; Hematology and Oncology Department, Morales Meseguer University Hospital, Murcia, Spain.
  • Nieto-Olivares A; Pathology Department, Morales Meseguer University Hospital, Murcia, Spain.
  • Aguayo-Albasini JL; General Surgery Department, Morales Meseguer University Hospital, Murcia, Spain.
Surg Oncol ; 38: 101629, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34171793
ABSTRACT

AIM:

To determine predictive factors of axillary lymph node dissection (ALND) results in breast cancer (BC) patients undergoing neoadjuvant chemotherapy (NACT), and subsequent staging using Targeted Axillary Dissection (TAD). MATERIAL AND

METHOD:

Case-control study between January 2016 and August 2019. Patients with BC, cN1 staging, marked with a metallic clip prior to NACT, and subsequently staged with TAD and ALND were included. They were divided into 2 groups ALND patients with or without metastatic involvement (group 1 and group 2, respectively). We carried out a univariate analysis comparing clinical, radiological, surgical and pathological variables, and a logistic regression, (dependent variable positive result of ALND; independent variables number of suspicious lymph nodes in diagnostic ultrasound, positive hormone receptors, HER2 positive, complete clinical-radiological response to NACT, positive TAD, and biopsy of ≤2 nodes in TAD). A score for prediction of a metastatic ALND was proposed, with an internal validation study.

RESULTS:

60 patients were included Group 1 33 (55.0%); Group 2 27 (45.0%). Tumor size (Odds Ratio (OR) = 1.67; 95%CI 1.02-2.74), number of suspected nodes in ultrasound (OR = 2.20; 95%CI 1.01-4, 77), HER2 positive (OR 0.04; 95%CI 0.003-0.54), clinical-radiological response to NACT (OR = 0.07; 95%CI 0.01-0.75), and positive TAD (OR 15.48; 95%CI 1.68-142.78) were independent predictors of a positive result in ALND. We developed a "positive ALND predictive score", with good calibration (Hosmer-Lemeshow test p = 0.65), and discrimination (AUC = 0.93; 95% CI 0, 87-0.99), with highest Youden index (0.7) at cut-off point of 17% risk of positive ALND (sensitivity = 100%; specificity = 70%).

CONCLUSION:

Tumor size, number of suspected nodes, positive HER2, response to NACT, and metastatic TAD are independent predictors of ALND. The predictive score for positive ALND would be a good indicator to safely omit ALND.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Escisión del Ganglio Linfático / Ganglios Linfáticos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Escisión del Ganglio Linfático / Ganglios Linfáticos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article